Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies

por Zhu, Qing-Ge, Zhang, Shi-Ming, Ding, Xiao-Xiao, He, Bing, Zhang, Hu-Qin
Publicado no Oncotarget (2017)

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis

por Zhang, Shi-Ming, Zhu, Qing-Ge, Ding, Xiao-Xiao, Lin, Song, Zhao, Jing, Guan, Lei, Li, Ting, He, Bing, Zhang, Hu-Qin
Publicado no Cancer Manag Res (2018)

Identifying key regulating miRNAs in hepatocellular carcinomas by an omics’ method

por He, Bing, Lu, Peng, Guan, Lei, Li, Ting, Zhang, Lei, Zhu, Qing-Ge, Ding, Xiao-Xiao, Zhang, Shi-Ming, Chen, Xue-Mei, Zhao, Jing, Lin, Song, Liu, Zhi-Zhen, Liu, Fang-E, Ma, Wang, Zhang, Hu-Qin
Publicado no Oncotarget (2017)

Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy

por Ding, Xiao-Xiao, Zhu, Qing-Ge, Zhang, Shi-Ming, Guan, Lei, Li, Ting, Zhang, Lei, Wang, Shi-Yang, Ren, Wan-Li, Chen, Xue-Mei, Zhao, Jing, Lin, Song, Liu, Zhi-Zhen, Bai, Yan-Xia, He, Bing, Zhang, Hu-Qin
Publicado no Oncotarget (2017)

MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma

por Guan, Lei, Li, Ting, Ai, Nanping, Wang, Wei, He, Bing, Bai, Yanxia, Yu, Zhaocai, Li, Mingyue, Dong, Shanshan, Zhu, Qingge, Ding, Xiao Xiao, Zhang, Shiming, li, Ming, Tang, Guangbo, Xia, Xiaochun, Zhao, Jing, lin, Song, yao, Shi, zhang, Lei, chen, Geng, Liu, Fang-E, Li, Xinyuan, Zhang, Huqin
Publicado no J Exp Clin Cancer Res (2019)